GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panion & Bf Biotech Inc (TPE:1760) » Definitions » Ending Cash Position

Panion & Bf Biotech (TPE:1760) Ending Cash Position : NT$505 Mil (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Panion & Bf Biotech Ending Cash Position?

Panion & Bf Biotech's Ending Cash Position for the quarter that ended in Mar. 2025 was NT$505 Mil.

Panion & Bf Biotech's quarterly Ending Cash Position increased from Sep. 2024 (NT$443 Mil) to Dec. 2024 (NT$558 Mil) but then declined from Dec. 2024 (NT$558 Mil) to Mar. 2025 (NT$505 Mil).

Panion & Bf Biotech's annual Ending Cash Position increased from Dec. 2022 (NT$464 Mil) to Dec. 2023 (NT$535 Mil) and increased from Dec. 2023 (NT$535 Mil) to Dec. 2024 (NT$558 Mil).


Panion & Bf Biotech Ending Cash Position Historical Data

The historical data trend for Panion & Bf Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panion & Bf Biotech Ending Cash Position Chart

Panion & Bf Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 310.11 279.10 464.26 534.63 558.37

Panion & Bf Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 476.21 581.86 442.70 558.37 505.08

Panion & Bf Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Panion & Bf Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=534.625+23.746
=558

Panion & Bf Biotech's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=558.371+-53.289
=505


Panion & Bf Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Panion & Bf Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Panion & Bf Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company along with its subsidiaries is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has two geographic segments Taiwan segment and China, Hong Kong, and Macau segment. It generates a majority of its revenue from the Taiwan segment.

Panion & Bf Biotech Headlines

No Headlines